C4 Therapeutics

• NCT07284758

  Phase 2, Recruiting, 100 people, 16 Dec 2025

• NCT05668585

  Phase 1, Completed, 89 people, 30 Dec 2022

• NCT04756726

  Phase 1, Active, not recruiting, 224 people, 16 Feb 2021

• Stromal cell senescence augments haematopoietic cell fitness in clonal haematopoiesis

  Consulting or advice, 6 Aug 2026

• Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness

  Consulting or advice, 25 Nov 2025

• Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis

  Consulting or advice, 28 Jan 2019

Sources: pubmed.ncbi.nlm.nih.gov